Study of Positive Psychology and Effects on Well-being of Anaesthesiologists in Hong Kong

November 19, 2023 updated by: Hong Kong College of Anaesthesiologists

Implementation of Structured Positive Psychology Interventions to Improve Well-being and Resilience Amongst Anaesthesiologists in Hong Kong

This clinical trial aims to evaluate whether positive psychology interventions via a hybrid approach will enhance well-being and resilience amongst anaesthesiologists in Hong Kong.

The main questions it aims to answer are:

  • Is app-based positive psychology intervention effective in improving well-being of physicians?
  • Is app-based positive psychology intervention feasible amongst busy healthcare professionals?

Participants will be randomized to one of the two groups:

  • Four-week web-based interventions
  • Control group

Researchers will compare the intervention and control groups to see if the participants' benefit from the positive psychology intervention compared with not receiving it.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
54

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Hong Kong
      • Hong Kong, Hong Kong
        • Recruiting
        • The Hong Kong College of Anaesthesiologists
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Fellows/members of The Hong Kong College of Anaesthesiologists

Exclusion Criteria:

  • No exclusion criteria is applied

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Positive Psychology A & B
Module A and B
Behavioral: App-based Positive Psychology Intervention (A&B)
An app-based, evidence-based positive psychology intervention focusing on two modules: (A) Awareness & Positivity and (B) Meaning and Accomplishment
Experimental: Positive Psychology C & D
Module C and D
Behavioral: App-based Positive Psychology Intervention (C&D)
An app-based, evidence-based positive psychology intervention focusing on two modules: (C) Rapport & Conflict Management and (D) Compassion & Leadership
No Intervention: Control Group with no intervention

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Self-reported well-being
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Overall well-being score of the Workplace PERMA-Profiler (Butler & Kern, 2016). This questionnaire consists of 23 items on a 10-point Likert scale from 0 = not at all to 10 = completely. The scale measures five pillars of well-being: positive emotion (P), engagement (E), relationship (R), meaning (M), and accomplishment (A), along with filler questions measuring negative emotion (N) and health (H). A overall well-being score is calculated to represent the person's well-being.
4 weeks (Change from baseline to within 7 Days post-intervention)
Self-reported burnout
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Overall burnout score of Copenhagen Burnout Inventory (CBI) (Kristensen, Borritz, Villadsen, & Christensen, 2005). This questionnaire consists of 19 items on a 5-point Likert scale from 1 = 0% (Never or almost never/To a very low degree) to 5 = 100% (Always/To a very high degree). The scale measures three domain of burnout: personal burnout, work-related burnout, and client-related burnout. A overall burnout score is calculated to represent the person's level of burnout.
4 weeks (Change from baseline to within 7 Days post-intervention)
Self-reported psychological stress
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Total stress score of Perceived Stress Scale (PSS-10) (Cohen et al., 1983). This questionnaire consists of 10 items on a 5-point Likert scale from 0 = Never to 4 = Very Often. The scale has two subscales: perceived helplessness and lack of self-efficacy. A total stress score is calculated to represent the person's level of psychological stress.
4 weeks (Change from baseline to within 7 Days post-intervention)
Self-reported anxiety symptom
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Total score of General Anxiety Disorder-7 (GAD-7) (Spitzer, Kroenke, Williams, & Löwe, 2006). This questionnaire consists of 7 items on a 4-point Likert scale from 0 = Not at all to 3 = Nearly every day. A total stress score is calculated to represent the person's anxiety symptom severity.
4 weeks (Change from baseline to within 7 Days post-intervention)
Self-reported depression symptom
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Total score of Patient Health Questionnaire-9 (PHQ-9) (Kroenke, Spitzer, & Williams, 2001). This questionnaire consists of 9 items on a 4-point Likert scale from 0 = Not at all to 3 = Nearly every day. A total stress score is calculated to represent the person's depression symptom severity.
4 weeks (Change from baseline to within 7 Days post-intervention)

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Self-reported self-compassion
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Self-Compassion Scale - Short Form (SCS-SF) (Raes, Pommier, Neff, & Van Gucht, 2011). This questionnaire consists of 12 items on a 5-point Likert scale from 1 = Strongly disagree to 5 = Strongly agree. The scale has six subscales: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. A total self-compassion score is calculated to represent the person's level of self-compassion.
4 weeks (Change from baseline to within 7 Days post-intervention)
Self-reported work gratitude
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Overall gratitude at work score of Work Gratitude Scale (Youssef-Morgan, van Zyl, & Ahrens, 2022). This questionnaire consists of 10 items on a 7-point Likert scale from 1 = Almost never to 7 = Almost always. The scale measures three components gratitude at work: grateful appraisals, gratitude toward others, and intentional attiude of gratitude. An overall gratitude at work score is calculated to represent the person's gratitude in one's work setting.
4 weeks (Change from baseline to within 7 Days post-intervention)
Self-reported work meaning
Time Frame: 4 weeks (Change from baseline to within 7 Days post-intervention)
Meaningful Work score of the Work and Meaning Inventory (Steger, Dik, & Duffy, 2012). This questionnaire consists of 10 items on a 5-point Likert scale from 1 = Absolutely untrue to 5 = Absolutely true. The scale has six subscales: self-kindness, self-judgment, common humanity, isolation, mindfulness, and over-identification. A overall Meaningful work score is calculated to represent the depth to which the person experience their work as meaningful, as something they are personally invested in, and which is a source of flourishing in one's life.
4 weeks (Change from baseline to within 7 Days post-intervention)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hong Kong College of Anaesthesiologists

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Albert Kam Ming Chan, The Hong Kong College of Anaesthesiologists

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 20, 2023

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 31, 2024

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 19, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 19, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
November 28, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 28, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 19, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • PosPsychology1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings